[go: up one dir, main page]

BR9504119A - Compound pharmaceutical composition methods for treating a bacterial infection and a mycoplasmic infection - Google Patents

Compound pharmaceutical composition methods for treating a bacterial infection and a mycoplasmic infection

Info

Publication number
BR9504119A
BR9504119A BR9504119A BR9504119A BR9504119A BR 9504119 A BR9504119 A BR 9504119A BR 9504119 A BR9504119 A BR 9504119A BR 9504119 A BR9504119 A BR 9504119A BR 9504119 A BR9504119 A BR 9504119A
Authority
BR
Brazil
Prior art keywords
infection
treating
pharmaceutical composition
mycoplasmic
compound pharmaceutical
Prior art date
Application number
BR9504119A
Other languages
Portuguese (pt)
Inventor
Burton H Jaynes
Kristin M Lundy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9504119A publication Critical patent/BR9504119A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BR9504119A 1994-09-22 1995-09-21 Compound pharmaceutical composition methods for treating a bacterial infection and a mycoplasmic infection BR9504119A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31128594A 1994-09-22 1994-09-22

Publications (1)

Publication Number Publication Date
BR9504119A true BR9504119A (en) 1996-08-06

Family

ID=23206224

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9504119A BR9504119A (en) 1994-09-22 1995-09-21 Compound pharmaceutical composition methods for treating a bacterial infection and a mycoplasmic infection

Country Status (5)

Country Link
AU (1) AU3121095A (en)
BR (1) BR9504119A (en)
CO (1) CO4410328A1 (en)
IL (1) IL115312A0 (en)
WO (1) WO1996009312A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605599B1 (en) 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
US20020111317A1 (en) * 2000-09-25 2002-08-15 Leonard Katz Sixteen-membered macrolide compounds
AU2003218110A1 (en) 2002-03-12 2003-09-29 Bristol-Myers Squibb Company C3-cyano epothilone derivatives
JP5323696B2 (en) 2006-07-28 2013-10-23 インターベツト・インターナシヨナル・ベー・ベー Macrolide synthesis method
JP6170064B2 (en) 2011-11-25 2017-07-26 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ Antibacterial tyrosine derivative and method for producing the same
NO2999707T3 (en) 2013-05-23 2018-08-25

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58146595A (en) * 1982-02-25 1983-09-01 Satoshi Omura Macrolide antibiotic
US4443436A (en) * 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
AU561147B2 (en) * 1982-09-13 1987-04-30 Eli Lilly And Company 20-amino macrolide antibiotics
JPS59181299A (en) * 1983-03-31 1984-10-15 Microbial Chem Res Found 20,23-dideoxy-20,23-bis-substituted amino-mycaminosylleronolide
JPS59227897A (en) * 1983-06-10 1984-12-21 Microbial Chem Res Found 20,23-dideoxy-23-alkyleneimino-20-substituted-mycaminosylleronolide
US4920103A (en) * 1986-09-29 1990-04-24 Eli Lilly And Company Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides
TW226373B (en) * 1992-07-15 1994-07-11 Pfizer
WO1995002594A1 (en) * 1993-07-15 1995-01-26 Pfizer Inc. Amide derivatives of 16-membered ring antibiotic macrolides

Also Published As

Publication number Publication date
IL115312A0 (en) 1995-12-31
WO1996009312A1 (en) 1996-03-28
AU3121095A (en) 1996-04-09
CO4410328A1 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
BR9500659A (en) Compound pharmaceutical composition and method of treating or preventing a condition caused by a bacterial injection
BR9602001A (en) Compound pharmaceutical composition method for inhibiting metallproteinases method for treating a condition
BR9608773A (en) Bacterial treatment for silage
BR9504072A (en) Pharmaceutical composition methods for the treatment of atherosclerosis hypercholesterolemia and kit
FI940932L (en) Compositions and methods for treating wounds
BR9500784A (en) Compound and pharmaceutical formulation
BR9504060A (en) Compound and pharmaceutical formulation
FI960751A7 (en) Substituted azaindolylidene compounds and method for their preparation
EE9500064A (en) Substituted 1H-imidazoles, methods for their preparation, and pharmaceutical compositions
BR9602628A (en) Compound pharmaceutical composition method for treating a condition and method for decreasing apo b secretion in a mammal
DK0797551T3 (en) Cement-like composition
BR9610836A (en) Antibacterial composition for oral administration
FI971750A7 (en) Compositions for multiple sclerosis and its treatment
BR9506642A (en) Composition and method for protecting a plantation against pathogenic diseases
FI953369L (en) Pharmaceutical compositions for preventing and treating cancer and a method for their preparation
FI951856L (en) Pharmaceutical composition for treating osteoporosis
FI951060L (en) Formulations and treatment methods
BR9505995A (en) Compound method for treatments and pharmaceutical composition
BR9507768A (en) Pharmaceutical composition
BR9708864A (en) Compound pharmaceutical composition and process for the treatment or prevention of a bacterial infection in a mammalian patient
BR9504119A (en) Compound pharmaceutical composition methods for treating a bacterial infection and a mycoplasmic infection
FI964271A7 (en) Method for stabilizing compound DX-52-1 and lyophilized composition thereof
FI933642A7 (en) Composition and methods for forming bone
FI955123A0 (en) Cholestyramine-containing composition and method for its preparation
FI953260A7 (en) Pharmaceutical compositions and method for their preparation

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law